Pyoderma gangrenosum in association with Janus kinase 2 (JAK2V617F) mutation. (Q54510114)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Pyoderma gangrenosum in association with Janus kinase 2 (JAK2V617F) mutation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

J A Palanivel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

A E Macbeth

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

21 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Dermatology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

44-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

The JAK/STAT signaling pathway

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2012.04375.X

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2012.04375.X

Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2012.04375.X

Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2012.04375.X

Targeting myeloproliferative neoplasms with JAK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2012.04375.X

10.1111/J.1365-2230.2012.04375.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607468%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference